Key result
Experiencing at least one adverse pregnancy outcome was associated with an increased long-term risk of ischaemic heart disease, with risk rising for multiple outcomes.
Why the study?
Do adverse pregnancy outcomes increase the long-term risk of ischaemic heart disease in women?
Cohort (n=2,195,266)
Yes
Do adverse pregnancy outcomes increase the long-term risk of ischaemic heart disease in women?
Answers are grounded in this paper and cite their sources.
Adverse pregnancy outcomes are independently associated with an increased long-term risk of ischaemic heart disease, highlighting the need for early cardiovascular prevention in affected women.
Comment on ‘Adverse pregnancy outcomes and long-term risk of ischaemic heart disease in mothers: national cohort and co-sibling study’, recently published in the BMJ, https://doi.org/10.1136/bmj-2022-072112. This national cohort study of 2 195 266 women with a first singleton delivery in Sweden between 1973 and 2015 aimed to explore the associations between adverse pregnancy outcomes (APOs) and the long-term risk of ischaemic heart disease (IHD).1 Five major APOs were identified from prenatal and birth records in the Swedish Medical Birth Register: preterm delivery, a small for gestational age infant, pre-eclampsia, other hypertensive disorders of pregnancy, and gestational diabetes. IHD was defined using the international classification of diseases-8, -9, and -10 codes, and included acute myocardial infarction (AMI), angina pectoris, and other types of acute or chronic IHD. The study cohort was followed up for the earliest diagnosis of IHD from first delivery to 31 December 2018. Median follow-up time was 25 years. Analyses were adjusted for other APOs and for maternal factors, including age, socio-demographic factors, parity, and traditional cardiovascular (CV) risk factors. Co-sibling analyses were carried out to assess for potential confounding by unmeasured shared familial (genetic and environmental) factors among women with at least one sister with singleton delivery. A total of 667 774 (30%) women experienced at least one APO. Median age at first delivery was 27 years, and the most frequent APOs were delivery of a small for gestational age infant (14.3%) and preterm delivery (8.8%). During 53.6 million person-years of follow-up, a diagnosis of IHD was made in 83 881 (3.8%) women. Median age at the time of IHD diagnosis was 59 years, and the most frequent IHD diagnoses were AMI (55%), followed by angina pectoris (39%), and other types of acute/chronic IHD (6%). All five APOs were independently associated with increased risk of IHD. Adjusted hazard ratios (HRs) for IHD were 1.56 [95% confidence interval (CI), 1.47–1.65] for other hypertensive disorders of pregnancy, 1.45 (95% CI, 1.38–1.52) for gestational diabetes, 1.39 (95% CI, 1.37–1.42) for pre-eclampsia, 1.33 (95% CI, 1.30–1.37) for preterm delivery, and 1.18 (95% CI, 1.16–1.20) for small for gestational age. The increased IHD risk in women with other hypertensive disorders of pregnancy was primarily driven by new onset hypertension during pregnancy (HR, 1.60; 95% CI, 1.51–1.70) rather than chronic hypertension (HR, 1.12; 95% CI, 0.91–1.38). The IHD risk associated with most APOs was highest in the first 10 years after delivery and then declined, albeit remaining significantly increased even 30–46 years after delivery. Pre-eclampsia and gestational diabetes were associated with the greatest excess of IHD diagnoses across the whole follow-up period (122 and 113 per 100 000 person-years, respectively). Co-sibling analyses resulted in partial attenuation of most risk estimates. The IHD relative rate progressively increased with the number of APOs experienced by the same women, with adjusted HRs ranging from 1.29 (95% CI, 1.19–1.39) in women with 1 APO to 1.80 (95% CI, 1.59–2.03) and 2.26 (95% CI, 1.89–2.70) in those with 2 and ≥3 APOs, respectively. There was also evidence for some synergistic effects in women who experienced multiple APOs. Despite a decrease in CV mortality across the general population over the past four decades, mortality rates in women aged 35–54 years continue to increase, primarily driven by IHD.2 There is a growing recognition that traditional CV risk scores underestimate IHD risk in women, classifying the vast majority of them as low risk. This is largely due to the fact that risk calculators fail to account for non-traditional risk factors unique to or more common in women.3 Pregnancy determines several metabolic, vascular, and physiological adaptations in the mother, including increased insulin resistance, adipose deposition, hypercoagulability, cardiac remodelling, and reduced vascular resistance.4,5 The physiological stress of pregnancy may trigger APOs, which often share some common pathogenetic features, including inflammation and vascular dysfunction.5 Experiencing an APO may in turn exacerbate pre-existent CV and metabolic risk or elicit new risk of IHD. Most APOs are in fact associated with future development of CV risk factors (e.g. hypertension, diabetes, and dyslipidaemia), which may, in part, mediate the increased risk of late IHD that has consistently been observed in previous studies and meta-analyses.6,7 Yet, due to the retrospective design of most previous studies that usually assessed single self-reported APOs in relation to future CV risk, as well as to the lack of detailed pregnancy history in most existing cohorts, evidence has been inconclusive so far. The present study has the advantage of using prospectively ascertained, nationwide birth and medical registry data of a cohort of more than 2 million pregnant women with up to 46 years of follow-up.1 This study design allowed to minimize potential selection and ascertainment biases, and provided adequate statistical power for simultaneous assessment of multiple APOs in relation to IHD risk. Women who experienced any of five major APOs showed an increased risk of subsequent IHD across the entire follow-up, and this risk was higher in case of multiple APOs. However, given the overlap in risk factors for APOs and cardiovascular disease, causality cannot be established and the contributing roles of specific APOs in the development of IHD cannot be ascertained from these data. Another study from the Swedish National Medical Birth Register recently demonstrated an independent risk of developing coronary artery disease (CAD) as assessed by computed tomography angiography following a hypertensive disorder of pregnancy (i.e. gestational hypertension or pre-eclampsia). Interestingly, this association was not observed with other APOs after adjustment for clinical factors, suggesting that most of the risk experienced by individuals with a history of other APOs, such as gestational diabetes, might be primarily mediated by conventional CV risk factors.8 Prior attempts to incorporate APOs into CV risk scores failed to provide meaningful reclassification of risk.8 This may be partly due to their lower prevalence compared with traditional CV risk factors. Although the present study results were adjusted for multiple CV risk factors, as well as for unmeasured shared familial factors using co-sibling analyses, residual confounding cannot be excluded. Several data, in fact, were missing in the Registry that are expected to influence CV risk, such as maternal smoking, obesity, and behavioural factors (e.g. physical activity and diet). Also, whether pregnancy-associated changes in blood pressure and/or glycaemic control later developed into hypertension and/or diabetes was not ascertained. Furthermore, no information on lactation/breastfeeding or pharmacotherapy was available. Of note, there is consistent evidence that a history of lactation/breastfeeding is associated with a lower risk of myocardial infarction, CAD, and IHD later in life.9 Another important limitation is that this study was confined to a Swedish cohort, from a moderate CV risk region,3 so that results cannot be generalized to other races or ethnicities. Of note, Black and Asian women have higher incidences of APOs, with more severe clinical presentation and worse outcomes, when compared with White women.5,10 Although some organizations recommend that evaluation of CV risk in women routinely includes taking a history of APOs, these complications still remain under-recognized as potential CV risk factors, especially in primary care where most women are managed. APOs may represent a useful window into long-term CV risk of women, thus providing a rationale for helping them engage in CV prevention at an earlier age. However, additional longitudinal studies integrating genetic analyses with pre- and post-pregnancy phenotyping will be required to establish whether APOs are indeed causally related to future development of IHD. No data were generated or analysed for this manuscript. All authors declare no funding for this contribution.
No takes yet. Share an insight, caveat, or question.
Vergallo et al. (2023) conducted a cohort in Ischaemic heart disease (n=2,195,266). Adverse pregnancy outcomes vs. No adverse pregnancy outcomes was evaluated on Ischaemic heart disease (IHD) (HR 1.29, 95% CI 1.19-1.39). Experiencing at least one adverse pregnancy outcome was associated with an increased long-term risk of ischaemic heart disease, with risk rising for multiple outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: